Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative transcriptomic analysis identifies conserved abiotic stress-responsive hub genes in Sorghum bicolor.

BMC plant biology·2026
Same author

Investigating bioactive potential of the Serratia sp. CS01 and its pigment for anti-inflammatory, antioxidant and antibacterial action.

Scientific reports·2026
Same author

Machine learning-assisted screening of natural product database for the identification of novel chalcone-based derivative as a potent DHODH inhibitor in cancer therapy.

Discover oncology·2026
Same author

Unveiling the potential of apigenin and kaempferol against colon cancer: an integrated network pharmacology and docking approach.

Frontiers in bioinformatics·2026
Same author

Design and optimization of peptidomimetics as PD-1/PD-L1 modulators for the management of triple-negative breast cancer.

In silico pharmacology·2026
Same author

Polypharmacological Exploration of Petroselinum Crispum for Antifibrotic Therapeutics: from Herb to Hepatoprotection.

Applied biochemistry and biotechnology·2026

Related Experiment Video

Updated: May 21, 2026

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

Discovering TEAD4 modulators for hepatocellular carcinoma: a GAN-enabled generative modelling framework.

Varshni Premnath1, Ramanathan Karuppasamy1, Jayakumar Kaliappan2

  • 1Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Frontiers in Bioinformatics
|May 20, 2026
PubMed
Summary

Researchers developed a computational method using generative adversarial networks (GANs) and XGBoost to identify potential TEAD4 inhibitors for liver diseases. Cholecalciferol (DB00169) was identified as a promising candidate, demonstrating a scalable strategy for drug discovery.

Keywords:
Hippo-YAP signalingTEAD4density functional theorygenerative adversarial networksliver diseases

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Related Experiment Videos

Last Updated: May 21, 2026

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Area of Science:

  • Drug Discovery
  • Computational Chemistry
  • Hepatology

Background:

  • Liver diseases pose a significant global health challenge.
  • Limited availability of validated small-molecule modulators hinders therapeutic progress.
  • TEAD4, a key regulator in liver biology, is pharmacologically underexplored due to a scarcity of inhibitors.

Purpose of the Study:

  • To develop a computational framework for identifying novel TEAD4 modulators.
  • To expand the chemical space for TEAD4-targeted drug discovery using data augmentation.
  • To discover potential drug candidates for treating liver diseases.

Main Methods:

  • Utilized a conditional generative adversarial network (GAN) trained on molecular descriptors for data augmentation.
  • Employed XGBoost classification for robust activity prediction on augmented datasets.
  • Screened the DrugBank database and refined hits using structure-based evaluation and toxicity filtering.

Main Results:

  • Identified DB00169 (cholecalciferol) as a potential TEAD4-binding candidate through quantum chemical analysis.
  • Molecular dynamics simulations confirmed the stability of the cholecalciferol-TEAD4 complex.
  • The integrated approach successfully generated a focused set of high-confidence TEAD4 modulator candidates.

Conclusions:

  • Coupling GAN-based augmentation with XGBoost classification and molecular simulations offers a scalable strategy.
  • This approach facilitates the identification of biologically meaningful TEAD4 modulators.
  • The findings support TEAD4-targeted drug discovery for various liver diseases.